Today, Soliton Inc Inc’s (NASDAQ: SOLY) stock gained $0.04, accounting for a 0.19% increase. Soliton opened at $20.62 before trading between $20.81 and $20.39 throughout Monday’s session. The activity saw Soliton’s market cap rise to $446,832,495 on 90,189 shares -below their 30-day average of 123,415.
About Soliton Inc
Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. TheCompany’s first FDA cleared commercial product, RESONIC™, will use rapid pulses of acoustic shockwaves as an accessory to lasers for the removal of unwanted tattoos and the treatment of cellulite. The Company is based in Houston, Texas, and is actively engaged in bringing RESONIC to the market. The Company believes this “Soliton” method has the potential to lower tattoo removal costs for patients, while increasing profitability to practitioners, compared to current laser removal methods. The Company also believes the technology will provide the first non-invasive acoustic technology to target the underlying causes of dimples and ridges in cellulite. Soliton is investigating potential additional capabilities of the RAP technology. The device is currently cleared in the United States only for use in tattoo removal and cellulite.